Overview

A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period

Status:
Terminated

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period.

Phase:

Phase 4

Details

Lead Sponsor:

Bukwang Pharmaceutical

Treatments:

Clevudine